Tag: cost, quality & value
Drug Rebates: New Executive Order Only Addresses Part of the Problem
Drug rebates often mean consumers pay more for drugs. Manufacturers raise list prices to cover PBM rebates. We pay a percent of list price.
Reshaping Healthcare: What We Can Learn From Alaska
Southcentral Foundation in Alaska provides excellent healthcare for half the money spent on other patients in that state. What can we learn from them?
Health Care Companies’ Critical Role in Responding to COVID-19
Richard Migliori MD, EVP & Chief Medical Officer of UnitedHealth Group describes the health care company's multi-pronged response to the COVID-19 pandemic.
The Value of Transparency in Payer-Provider Relationships
Doctors, patients, and insurers can all benefit from improved transparency in payer-provider relationships in areas ranging from costs to care management.
Opening a Medical Practice? Here’s How to Overcome the Challenges
If you are thinking about opening a medical practice, you need to know about these three common challenges and how to overcome them.
What is the Impact of Dementia on Comorbid Conditions?
New research finds that dementia has a substantial impact on the costs and prevalence of certain common comorbid conditions compared with matched individuals without dementia.
The Promise of Failure Analysis in Healthcare
The makers of Learjet collect data & program what is learned about critical system failures in order to improve flight safety. Healthcare should do the same.
Quality is the Key to Healthcare Value
America’s healthcare value crisis is rooted in the failure to focus on managing quality. However, some providers have systematically improved quality with outstanding results.
How to Fix Part B Drug Fail-First Policies that Harm Seniors
Adding step-therapy to Medicare Advantage Part B drugs can delay access to effective medications putting patients at risk. 3 easy tweaks can mitigate the risk.
Lowering Cost-Share for High Value Meds Improves Adherence
A recent study shows that value-based insurance desig reduces consumer cost-sharing for clinically indicated medications and increases adherence without changing total spending.
High-Value Healthcare: Is It the Wave Of The Future?
There's a growing number of providers committed to delivering high-value care & a group of purchasers willing to go around traditional arrangements to access it.
The State of U.S. Healthcare: An Iron Cage of Bureaucracy
Even as Americans are forced to resign to healthcare costs that have reached an all-time high, it is indisputable that patients continue to pay more while receiving less. Administrative costs related to wasteful bureaucracy is a major contributor.